Skip to main content
Erschienen in: BMC Infectious Diseases 1/2016

Open Access 01.12.2016 | Research article

Travelers’ health problems and behavior: prospective study with post-travel follow-up

verfasst von: Katri Vilkman, Sari H. Pakkanen, Tinja Lääveri, Heli Siikamäki, Anu Kantele

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2016

Abstract

Background

The annual number of international tourist arrivals has recently exceeded one billion, yet surprisingly few studies have characterized travelers’ behavior, illness, and risk factors in a prospective setting. Particularly scarce are surveys of data spanning travel, return, and follow-up of the same cohort.
This study examines behavior and illness among travelers while abroad, after return home, and at follow-up. Patterns of behavior connected to type of travel and illness are characterized so as to identify risk factors and provide background data for pre-travel advice.

Methods

Volunteers to this prospective cohort study were recruited at visits to a travel clinic prior to departure. Data on the subjects’ health and behavior were collected by questionnaires before and after journeys and over a three-week follow-up. In addition, the subjects were asked to fill in health diaries while traveling.

Results

The final study population consisted of 460 subjects, 79 % of whom reported illness during travel or on arrival: 69 % had travelers’ diarrhea (TD), 17 % skin problems, 17 % fever, 12 % vomiting, 8 % respiratory tract infection, 4 % urinary tract infection, 2 % ear infection, 4 % gastrointestinal complaints other than TD or vomiting, and 4 % other symptoms. Of all subjects, 10 % consulted a doctor and 0.7 % were hospitalized; 18 % took antimicrobials, with TD as the most common indication (64 %). Ongoing symptoms were reported by 25 % of all travelers upon return home.
During the three-week follow-up (return rate 51 %), 32 % of respondents developed new-onset symptoms, 20 % visited a doctor and 1.7 % were hospitalized.
Factors predisposing to health problems were identified by multivariable analysis: certain regions (Southern Asia, South-Eastern Asia, and Eastern Africa), female gender, young age, and long travel duration.

Conclusions

Despite proper preventive measures like vaccinations, malaria prophylaxis, and travel advice, the majority of our subjects fell ill during or after travel. As the symptoms mostly remained mild, health care services were seldom needed. Typical traveler profiles were identified, thereby providing a tool for pre-travel advice. The finding that one third reported new-onset illness during follow-up attests to the importance of advising clients on potential post-travel health problems already during pre-travel visits.
Begleitmaterial
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​s12879-016-1682-0) contains supplementary material, which is available to authorized users.

Background

According to travel records for 2015, the number of international tourist arrivals exceeded one billion, and half a billion people headed to emerging economies [1]. Less than half of the visitors to poor regions have been shown to seek pre-travel health advice, as exemplified by only 15 % of Canadians visiting hepatitis A endemic countries [2] and 31 % of Australasians traveling to Asia, Africa, or South America [3]. This is surprising, considering the high morbidity rates (64–70 %) reported for visitors to developing regions [4, 5].
Investigations addressing travelers’ health have generally been retrospective and/or conducted among those seeking medical care after their journeys [621]. Not many prospective studies focus on the spectrum of travelers’ diseases [4, 5, 2227]. Among these we found only one that looks at the same cohort during and after travel and also includes a post-travel follow-up [4]. The principal findings of the prospective studies are mildness of symptoms [4, 22] and small proportion of those falling ill who seek medical care: 2–33 % of the total study population visit a physician and 0.1–4 % are hospitalized [4, 5, 22, 24, 25, 27] during travel. After returning home, 9–20 % of all travelers have been reported to see a doctor [4, 5, 22, 25] and 0.0–1.0 % to be hospitalized [4, 22, 27]. Even though those with the most severe symptoms probably seek medical care, it should be noted that they represent only the tip of the iceberg among travelers falling ill. To get a comprehensive view of travel-associated health problems, prospective study designs should be employed for collecting data on illness while abroad, after return, and at follow-up.
To examine the health problems of travelers overseas, we recently conducted a nation-wide study of a large Finnish database provided by an assistance organization [21]. While these data presumably cover cases with the most severe symptoms, we sought to complete them with a prospective study that would comprise even mild illness. By including a post-travel follow-up, we extended the research to symptoms not developing until after return.

Methods

Volunteers and study design

Volunteers to this prospective study cohort were enrolled at the Travel Clinic of Aava Medical Centre among travelers planning a journey outside the Nordic countries for a minimum of four days and a maximum of six months (Fig. 1). The only exclusion criterion was non-compliance in returning questionnaires. The subjects were recruited among consecutive clients at pre-travel appointments between December 2008 and February 2010. At the initial visit, they filled out a pre-travel questionnaire (Q1), on return home a post-travel questionnaire (Q2), and about three weeks later a follow-up questionnaire (Q3). Those who failed to return both Q1 and Q2 were excluded. In addition to the questionnaires, the subjects were asked to complete a structured diary on a voluntary basis. All volunteers were given pre-travel advice by a health care professional.
We have earlier reported risk factors for acquiring resistant intestinal microbes in the same population [28], and, data on diarrheal pathogens, first in our methodological investigation [29] and, recently, in an etiological study [30].

Questionnaires

The questionnaires consisted of 134 multiple-choice or open-ended questions: Q1 comprised 47, Q2 60, and Q3 27 questions. These questionnaires were modified from a set of survey questions routinely used for more than 10 years for ill travelers admitted to the Clinic of Infectious Diseases at HUCH. All items covered are listed in Fig. 1. The structured diary contained more specific questions on duration and severity of symptoms, and use of antibiotics.

Definitions

Subjects were classified as ill if they reported symptoms implying health problems which could be travel-related. Diarrhea was defined according to WHO criteria, i.e. passage of 3 or more loose or liquid stools per day, or more frequently than is normal for the individual (World Health Organization [31]). At follow-up, symptoms which had set in more than two days after a journey and could be travel-related were categorized as newly onset.

Destinations

The countries visited were grouped into nine geographic regions (UN categorization, modified [32]): Southern Asia, South-Eastern Asia, Eastern Asia and Central Asia, Southern Africa, Eastern Africa, Western Africa and Middle Africa, Northern Africa and Western Asia, Latin America and the Caribbean, and Europe and Northern America (Table 1). The destination with the greatest health risk was considered primary for subjects traveling to several places. Here we used a rating based on the risk map drawn up by International SOS (Additional file 1: Figure S1 HealthMap 2010) which takes into account a range of factors: the standard of local medical and dental care, access to prescription drugs, the possible prevalence of serious infectious diseases, and known cultural, linguistic and administrative barriers.
Table 1
Demographics, travel information, and destinations of 460 travelers recruited at the travel clinic during their pre-travel visit, all staying outside the Nordic countries for more than four days and less than 6 months. The data are given as numbers of cases and their proportions
 
Number
(%a)
Sex (missing data = 0)
 Male
173
(38)
 Female
287
(62)
Age, median (IQR) (missing data = 0)
35 (27.0–54.0)
 
 0–17, children
35
(8)
 18–35, young adults
196
(43)
 36–55, middle aged
120
(26)
 56–, older travelers
109
(24)
Underlying diseases (missing data = 0)
192
(42)
 Asthma, atopy and/or allergy
56
(12)
 Hypertension
51
(11)
 Psychiatric disorder or medication
25
(5)
 Cardiovascular disease
14
(3)
 GI disorder b
13
(3)
 Neurological disorder
12
(3)
 DM
9
(2)
 Rheumatic disease
6
(1)
 Other disease and conditions
78
(17)
 Contraceptives or postmenopausal hormone replacement therapy
53
(12)
Duration of travel, median in days (IQR) (missing data = 2)
16 (12.8–27.3)
 
 1 week or less (missing data = 0)
27
(6)
 More than a week and less than a month
334
(73)
 1–5 months
99
(22)
Purpose of travel (missing data = 1)
  
 Vacation
383
(83)
 Business
38
(8)
 Other/multiple c
38
(8)
Geographic region (missing data = 0) d
  
 South-Eastern Asia
107
(23)
 Eastern Africa
96
(21)
 Western Africa, Middle Africa
86
(19)
 Southern Asia
68
(15)
 Latin America and the Caribbean
41
(9)
 Southern Africa
26
(6)
 Europe, Northern America
15
(3)
 Northern Africa, Western Asia
12
(3)
 Eastern Asia, Central Asia
9
(2)
a Proportion of positive among those from whom information was available
b Crohn's disease, irritable bowel syndrome, primary biliary cirrhosis, diverticulosis, microscopic colitis, celiac disease
c 14 (3 %) travelers reported two or more purposes of travel
d Given according to primary destination. Categorized into three subgroups: Asia (Western Asia, South-Eastern Asia, Southern Asia, Eastern Asia, and Central Asia), Africa (Eastern Africa, Western Africa, Middle Africa, Southern Africa, and Northern Africa), and the others (Latin America and the Caribbean, Europe, North America)

Statistics

Univariable, bivariable and multivariable models were used. The p-value of Pearson Chi-square tests and Fisher’s exact test < 0.05 was considered statistically significant. If bivariable p-value was less than 0.10, the factor was chosen to the multivariable logistic regression model, and its adjusted odds ratios and 95 % confidence intervals were calculated. Missing data were assumed to be missing at random (MAR) and missing values were imputed using multiple imputations in SPSS. The statistical analyzes were carried out with SPSS Statistics (version 22.0.0.2, IBM Corp., USA).

Results

Cohort population and prophylactic measures

Of the 524 initially recruited travelers, 88 % completed both pre- and post-travel questionnaires. The final study population thus consisted of 460 volunteers (Fig. 1, Table 1). A total of 233 (51 %) returned follow-up questionnaires and 295 (64 %) filled in diaries. An underlying disease or condition was recorded for 192 (42 %)(Table 1), more frequently among the oldest subjects (56– years, 73 %; p < 0.001), and females (45 %; p = 0.046) than in other age groups (0–55 years, 23–38 %) or among males (36 %). Data on vaccinations are presented in Table 2 and on antimalarials in Table 3.
Table 2
Numbers and proportions of travelers (n = 460) vaccinated before the travel clinic appointment or at consultation. The data are given as numbers and percentages of those vaccinated or considered protected according to Finnish recommendations
 
Protected before consultation, N (%a)
Vaccinated at consultation, N (%a)
Protected according to recommendations given for the region visited, N (%a)
Tetanus (missing data = 4)
353 (77)
96 (21)
449 (98)
MMR (missing data = 43)
393 (94)
21 (5)
414 (99)
Hepatitis A (missing data = 3)
325 (71)
130 (28)
440 (100)
Hepatitis B (missing data = 4)
178 (39)
124 (27)
72 (73)
Yellow Fever (missing data = 2)
112 (24)
153 (33)
182 (96)
Polio (missing data = 4) b
140 (31)
84 (18)
104 (63)
Typhoid fever (missing data = 3)
38 (8)
63 (14)
47 (65)
oral
16 (4)
59 (13)
 
injected
22 (5)
4 (1)
 
Japanese encephalitis (missing data = 3) c
15 (3)
30 (7)
18 (53)
Other (missing data = 3) d
14 (3)
58 (13)
 
aProportion of positive among those from whom information was available
bPart of the volunteers may have chosen to skip polio vaccination during appointment at the travel clinic and, instead, get it from their health center where they are vaccinated free of charge since polio is included in the Finnish national immunization program
cDespite advice many declined prophylaxis because of high price
dIncludes cholera, meningococcal, and rabies vaccinations
Table 3
Medications taken by 460 Finnish travelers during the trip. The medications are categorized according to indication. The data are presented as numbers and percentages of travelers
 
Number
(%a)
Prophylactic antimalarial use among those recommended (missing data = 6)
289
(98)
 Atovaquone and proguanil
135
(30)
 Mefloquine
70
(15)
 Doxycycline
55
(12)
 Chloroquine
25
(6)
 Other / not known
2
(0)
 Changed drug b
2
(0)
 Failure in use c
7
(2)
Antimicrobials (other than doxicycline) (missing data = 0) d
81
(18)
 Fluoroquinolone
53
(12)
 Macrolide
9
(2)
 Nitroimidazole (metronidazole or tinidatzole)
7
(2)
 Amoxicillin
5
(1)
 Tetracycline
1
(0)
 Other / not known
25
(5)
 Two or more antimicrobials (without doxycycline)
15
(3)
Treatment for malaria (missing data = 0) e
4
(1)
Gastrointestinal medication (missing data = 0)
127
(28)
 Loperamide
115
(25)
 Medicinal charcoal
7
(2)
 Other (laxative, spasmolyte, co-phenotrope)
10
(2)
 Two or more gastrointestinal medications
5
(1)
Analgesic (missing data = 0)
123
(27)
 NSAID
67
(15)
 Paracetamol
59
(13)
 Other / not known
16
(3)
 Two or more analgesics
18
(4)
Antiemetic (missing data = 0)
4
(1)
PPI or antacid (missing data = 4)
36
(8)
 PPI
26
(6)
 Antacid (salts/H2)
10
(2)
Probiotics and prebiotics (missing data = 3) f
270
(59)
 Starting before travel
11
(2)
 Using only during travel
123
(27)
 Starting before and using during travel
136
(30)
a Total use of all travelers among those from whom information was available
b Each of these changed the medication from doxycycline to mefloquine
c Did not use as recommended (2 did not take at all, 1 stopped because of adverse effects, 4 used irregularly): atovaquone/proguanil (4), doxycycline (2), mefloquine (1); 10 had prescription but did not enter malaria area; 33 traveled to endemic countries yet visited only low prevalence areas
d 52 (11 % of all) used antimicrobials for TD
e All in Africa, three of four were tested; two negative, one positive
f If only product mentioned, presumed to be used while traveling

Travel information and behavior

The 460 travelers visited 77 countries altogether (UN definition); India (64), Thailand (60), Gambia (50), Tanzania (48), and Kenya (40) ranking as their most popular destinations. Overall 662 country visits were made (average 1.45 per person; range 1–8). The 30 most favored countries accounted for 560 journeys (85 %); only three destinations were in developed regions (UN definition [33]): USA (8), Spain (7), and the Netherlands (5).
Uncooked meat/fish (Table 4) was eaten more frequently by young adults (18–35 years, 17 %) and the middle-aged (36–55 years, 13 %) than children (0–17 years, 6 %) and older travelers (56– years, 6 %) (p = 0.016). Young adults proved more likely than the others to have freshwater contact, neglect hand washing, and not to shun salads or eating without utensils. Men consumed more alcohol than women (p < 0.001).
Table 4
Traveler profiles presented by demographics (destination, sex, age, duration of travel, purpose of travel) with travel behavior in bivariable analysis for 460 travelers. Results are given in percentages with the largest group shown in bold
 
Number (%)
Destination %
Sex %
Age group (years) %
Duration of travel (days) %
Purpose of travel %
Africa
Asia
other
p-value
male
female
p-value
0–17
18–35
36–55
56–
p-value
1–7
8–29
30–160
p-value
vacation
business
other
p-value
Age group (missing data = 0)
    
<0.001*
  
0.833
        
<0.001*
   
0.056
 0–17
35 (8)
8
7
11
 
8
7
      
30
7
3
 
9
0
3
 
 18–35
196 (43)
32
55
41
 
43
42
      
22
36
72
 
42
37
61
 
 36–55
120 (26)
30
23
23
 
27
25
      
33
29
13
 
26
39
16
 
 56–
109 (24)
31
15
25
 
21
25
      
15
28
12
 
24
24
21
 
Duration of travel, days (missing data = 0)
    
<0.001*
  
0.473
    
<0.001*
       
<0.001d*
 1–7
27 (6)
2
6
20
 
7
5
 
23
3
8
4
     
6
13
0
 
 8–29
334 (73)
81
63
73
 
72
73
 
69
61
82
85
     
79
53
29
 
 30–160
99 (22)
17
31
7
 
20
22
 
9
36
11
11
     
15
34
71
 
Purpose of travel (missing data = 1) a
    
0.034d*
  
0.002*
    
0.056
   
<0.001d*
    
 vacation
383 (84)
78
88
91
 
86
82
 
97
81
83
84
 
81
91
60
     
 business
37 (8)
12
5
4
 
11
7
 
0
7
13
8
 
19
6
13
     
 other/multiple
35 (8)
10
7
5
 
3
11
 
3
12
5
7
 
0
3
27
     
Accommodation (missing data = 11) b
    
<0.001*
  
0.008*
    
<0.001*
   
<0.001*
   
<0.001*
 hotel
188 (42)
39
40
61
 
46
40
 
34
31
50
55
 
85
46
15
 
44
45
18
 
 home of a local
71 (16)
23
9
14
 
9
20
 
26
16
11
17
 
15
12
29
 
12
16
50
 
 guest house
190 (42)
39
52
25
 
45
41
 
40
53
39
28
 
0
42
56
 
44
39
32
 
Location (missing data = 22) b
    
<0.001*
  
0.083
    
0.088
   
<0.001*
   
0.494
 city
143 (33)
24
34
57
 
28
36
 
44
27
36
38
 
88
31
23
 
33
38
25
 
 countryside/jungle
295 (67)
76
66
43
 
72
64
 
56
73
66
62
 
12
69
77
 
67
62
75
 
Used other than bottled water (missing data = 3) b
25 (5)
8
3
5
0.144
6
5
0.499
3
4
8
6
0.373
0
5
7
0.336
5
11
5
0.379d
Ate uncooked meat/fish (missing data = 4)
58 (13)
9
16
18
0.045*
11
14
0.446
6
17
13
6
0.016*
4
12
18
0.080
13
13
11
0.961d
Ate salads (missing data = 26)
341 (79)
77
78
85
0.427
79
78
0.904
59
83
81
74
0.009*
69
78
83
0.288
80
70
78
0.404
Diet (missing data = 159)
    
0.087
  
0.018*
    
0.010*
   
0.288
   
1.000d
 omnivore
274 (91)
92
88
100
 
96
88
 
100
85
92
97
 
100
92
88
 
91
91
93
 
 vegetarian
27 (9)
8
12
0
 
4
12
 
0
15
8
3
 
0
8
13
 
9
9
7
 
Used milk as part of diet (missing data = 161)
293 (98)
99
97
96
0.226d
99
97
0.426d
96
98
99
97
0.599d
100
99
96
0.347d
98
100
100
1.000d
Site of meals (missing data = 12) b
    
<0.001*
  
0.099
    
<0.001*
   
0.660
   
0.042*
 restaurant more than 50 %
372 (83)
70
96
87
 
87
81
 
53
86
86
83
 
89
83
81
 
84
83
68
 
 own household and sometimes elsewhere
76 (17)
30
4
13
 
13
19
 
47
14
14
17
 
11
17
19
 
16
17
32
 
Alcohol consumption (missing data = 67) c
    
0.112
  
<0.001*
    
0.001*
   
0.117
   
0.025*
 0–2 units per day
281 (61)
72
74
59
 
61
78
 
100
70
64
71
 
65
69
80
 
70
64
91
 
 3– units per day
112 (24)
28
26
41
 
39
22
 
0
30
36
29
 
35
31
20
 
30
36
9
 
Did not always use utensils (missing data = 23)
126 (29)
28
34
18
0.070
28
29
0.877
39
40
24
10
<0.001*
17
22
55
<0.001*
26
39
49
0.004*
Did not wash hands always/often (missing data = 13)
61 (14)
10
16
18
0.147
17
12
0.138
9
21
9
7
0.001*
11
13
17
0.573
14
14
11
0.840
No WC as a toilet (missing data = 7)
74 (16)
22
13
5
0.004*
17
16
0.747
16
19
18
10
0.235
0
16
21
0.037*
16
14
24
0.411
Had fresh water contact (missing data = 160)
109 (36)
27
47
28
0.001*
38
35
0.584
26
50
33
14
<0.001*
6
31
59
<0.001*
37
24
46
0.243
Walking barefoot often/sometimes (missing data = 7)
322 (71)
64
80
69
0.002*
74
69
0.326
88
79
68
55
<0.001*
65
70
77
0.359
74
59
55
0.015*
Unprotected sex with local (missing data = 27)
8 (2)
4
1
0
0.067d
2
2
1.000d
0
1
4
1
0.239d
0
2
3
0.632d
2
0
3
0.587d
Other close contact with local (kissing / sharing meals) (missing data = 26)
82 (19)
23
17
9
0.055
17
20
0.336
18
25
19
8
0.007*
8
15
36
<0.001*
17
24
33
0.039*
Had insect stings (missing data = 22)
335 (76)
75
81
67
0.058
75
77
0.657
59
88
75
62
<0.001*
19
77
93
<0.001*
76
65
91
0.032*
a 14 (3 %) reported two or more purposes of travel
b Categorized according to lowest standard
c Missing data for children under 16 years was replaced with 0 alcohol servings per day
d Fisher's exact test used
* P-value less than 0.05

Traveler profiles

Traveler profiles by age

The median duration of travel was 23 days for the young adults and 15 days for others (age group vs travel duration group p < 0.001). Young adults and children stayed most often in guest houses, while the others preferred hotel accommodation (Table 4).

Traveler profiles by destinations

To obtain data on typical travelers to the two most preferred geographic regions, Africa and Asia, the destinations were categorized into three subgroups: Africa (n = 212), Asia (n = 192), and others (n = 56). Their characteristics are presented in Table 4. In bivariable analysis, distribution of age and duration of journey differed between those heading for Africa and those favoring Asia. The median age was higher for those visiting Africa, and the journey was shorter. Likewise, compared to Asia, visitors to Africa had less frequent freshwater contact and ate uncooked meat/fish less often.

Illness

Factors with p < 0.1 in the bivariable analyses (Table 5) were included in the multivariable analyses (Table 6). Destination associated strongly with health problems. Females were more predisposed to falling ill. Overall, the risk was greatest at 31.5 years of age. The longer the travel, the greater the risk of contracting an illness – it increased each day by 2.5 %. Eating raw meat/fish was associated with healthier travelers.
Table 5
Risk factors of contracting illness while traveling / on arrival among 460 travelers. Values are given for proportions of ill travelers with a given risk factor, odds ratios with 95 % confidence intervals, and p-values in a bivariable analysis
 
Contracted illness a %
Odds ratio (95 % confidence interval)
p-value
Total (missing data = 1)
79
   
Sex (missing data = 0)
    
 Male
75
1.0
  
 Female
81
1.5
(1.0–2.4)
0.079*
Age group (missing data = 0)
   
<0.001*
 0–17
66
1.0
  
 18–35
89
4.3
(1.9–9.9)
0.001
 36–55
73
1.4
(0.6–3.2)
0.380
 56–
71
1.3
(0.6–2.8)
0.582
Geographic region (missing data = 0)
   
<0.001*
 Europe, Northern America
20
1.0
  
 Latin America and the Caribbean
66
7.7
(1.9–32.0)
0.005
 Northern Africa, Western Asia
67
8.0
(1.4–45.8)
0.019
 Southern Africa
62
6.4
(1.4–28.4)
0.015
 Western Africa, Middle Africa
79
14.9
(3.8–58.5)
<0.001
 Eastern Africa
84
21.6
(5.4–85.8)
<0.001
 Eastern Asia, Central Asia
56
5.0
(0.8–31.0)
0.084
 South-Eastern Asia
87
26.6
(6.7–106.1)
<0.001
 Southern Asia
91
41.3
(9.1–188.5)
<0.001
Duration of travel, days (missing data = 0)
   
<0.001*
 1–7
52
1.0
  
 8–29
77
3.0
(1.4–6.7)
0.006
 30–160
94
14.4
(4.7–44.1)
<0.001
Purpose of travel (missing data = 1)
   
0.813
 Vacation
78
1.0
  
 Business
82
1.2
(0.5–2.9)
0.636
 Other/multiple b
82
1.2
(0.5–2.9)
0.636
Accommodation (missing data = 11) c
   
<0.001*
 Hotel
68
1.0
  
 Home of a local
87
3.2
(1.5–6.8)
0.003
 Guest house
87
3.1
(1.8–5.2)
<0.001
Location (missing data = 22) c
    
 City
71
1.0
  
 Countryside/jungle
83
2.0
(1.3–3.3)
0.003*
Used other than bottled water (missing data = 3) c
76
0.8
(0.3–2.2)
0.710
Ate uncooked meat/fish (missing data = 4)
66
0.4
(0.2–0.8)
0.006*
Ate salads (missing data = 26)
78
0.7
(0.4–1.2)
0.192
Diet (missing data = 159)
    
 Omnivore
82
1.0
  
 Vegetarian
89
1.8
(0.5–6.2)
0.353
Used milk as part of diet (missing data = 161)
83
1.0
(0.1–8.5)
1.000e
Site of meals (missing data = 12) c
    
 Restaurant more than 50 % of meals
79
1.0
  
 Own household and sometimes elsewhere
79
1.0
(0.5–1.8)
0.996
Alcohol consumption (missing data = 67) d
    
 0–2 units per day
81
1.0
  
 3– units per day
74
0.7
(0.4–1.1)
0.102
Did not always use utensils (missing data = 23)
85
1.7
(1.0–3.0)
0.058*
Did not wash hands always/often (missing data = 13)
72
0.6
(0.3–1.2)
0.138
No WC as a toilet (missing data = 7)
85
1.6
(0.8–3.2)
0.159
Had fresh water contact (missing data = 160)
84
1.7
(0.9–3.1)
0.109
Walking barefoot often/sometimes (missing data = 7)
79
1.0
(0.6–1.7)
0.990
Unprotected sex with local (missing data = 27)
100
1.0
(1.0–1.0)
0.213e
Other close contact with local (missing data = 26)
88
2.2
(1.1–4.4)
0.030*
Had insect stings (missing data = 22)
84
3.1
(1.9–5.1)
<0.001*
a Symptoms started abroad or on return
b 14 (3 %) reported two or more purposes of travel
c Categorized according to lowest standard
d Missing data for children under 16 years was replaced with 0 alcohol servings per day
e Fisher's exact test used
* Factors with P-value <0.1 chosen to multivariable model
Table 6
Risk factors of contracting illness while traveling / on return in the final multivariable model after backward selection of factors by Akaike information criteriaa. Variables with p-value less than 0.10 in bivariable analysis were chosen to multivariable model. Values are given for proportions with a given risk factor, adjusted odds ratios with 95 % confidence intervals, and p-values in multivariable analysis
 
Proportion of those contracting
AOR (95 % CI) for contracting illness among
 
illness among travelers with
travelers with the given risk factor in multivariable
 
the given risk factor (%)
analysis with multiple imputations c
p-value
Gender
   
male
75
1.00
 
female
81
1.73 (1.03–2.91)
0.040*
Age, years b
N/A
1.06 (0.994–1.14)
0.076
Age, quadratic term b
N/A
0.999 (0.998–1.00)
0.018*
Geographic region
  
N/A
Europe, Northern America
20
1.00
 
Latin America and the Caribbean
66
7.90 (1.66–37.6)
0.009*
Northern Africa, Western Asia
67
11.9 (1.82–78.0)
0.010*
Southern Africa
62
9.72 (1.85–51.2)
0.007*
Western Africa, Middle Africa
79
15.5 (3.50–68.7)
<0.001*
Eastern Africa
84
18.5 (4.08–83.8)
<0.001*
Eastern Asia, Central Asia
56
6.41 (0.930–44.2)
0.059
South-Eastern Asia
87
21.2 (4.48–100)
<0.001*
Southern Asia
91
32.4 (6.24–168)
<0.001*
Duration of travel, days b
N/A
1.025 (1.00–1.05)
0.048*
Accommodation
  
N/A
hotel
68
1.00
 
home of a local
87
2.36 (0.922–6.06)
0.073
guest house
87
1.78 (0.940–3.36)
0.077
Eating uncooked meat/fish
   
did not eat uncooked meat/fish
81
1.00
 
ate uncooked meat/fish
66
0.303 (0.147–0.625)
0.001*
Abbreviations: AOR adjusted odds ratios, CI confidence interval, N/A not applicable
aBackward selection eliminated the following factors: location, other close contact with local, having insect stings, and use of utensils
bAnalyzed as continuous variables. Age also on quadratic term, which seems to be better than age only in the model by AIC
c10 datasets used in imputation
Geographic regions with demographics and proportions of sick travelers are presented in Fig. 2. Illness rates by geographic regions were found to accord with respective risk ratings by International SOS (Additional file 2: Figure S2).
Health care was sought by 10 % of all subjects and by 13 % of those fallen ill during travel; 10 % and 13 % visited a physician and 0.7 % and 0.9 %, respectively, were hospitalized (Table 7). The most common reason for consulting health care professionals while abroad was TD – 4 % of all travelers visited a doctor, and 0.4 % were subsequently admitted to hospital because of this illness.
Table 7
Symptoms and contacts to health care providers. Data are provided for 459 travelers as numbers and percentages separately for the period during travel, on return, and one month after it
 
During journey, N
Ongoing or started on arrival, N
Newly onset during follow-up, N
 
N/459 (%a)
N/453 (%a)
N/233 (%a)
Any symptom
351 (76)
113 (25)
74 (32)
 travelers' diarrhea
312 (68)
78 (17)
5 (2)
 skin problem b
78 (17)
2 (0)
9 (4)
 fever >37,5 °C
74 (16)
6 (1)
20 (9)
 vomiting
55 (12)
2 (0)
1 (0)
 respiratory tract infection
26 (6)
17 (4)
9 (4)
 urinary tract infection
17 (4)
1 (0)
4 (2)
 ear infection
5 (1)
4 (1)
1 (0)
 other gastrointestinal symptoms
19 (4)
2 (0)
4 (2)
 other symptoms
16 (3)
6 (1)
40 (17)
Contacts to health care
47 (10)
1 (0)
50 (21)
Outpatient contact with health care c
44 (10)
1 (0)
46 (20)
 travelers’ diarrhea
20 (4)
0 (0)
16 (7)
 skin problem d
9 (2)
0 (0)
5 (2)
 respiratory tract infection
8 (2)
0 (0)
5 (2)
 ear infection
4 (1)
0 (0)
1 (0)
 malaria / suspected malaria
3 (1)
0 (0)
0 (0)
 musculosceletal problem
2 (0)
0 (0)
6 (3)
 urinary tract infection
2 (0)
0 (0)
2 (1)
 other reason
3 (1)
1 (0)
11 (5)
Inpatient (hospitalization)
3 (1)
0 (0)
4 (2)
 travelers’ diarrhea
2 (0)
0 (0)
1 (0)
 fever >37,5 °C
0 (0)
0 (0)
1 (0)
 respiratory tract infection
0 (0)
0 (0)
1 (0)
 suspected malaria
0 (0)
0 (0)
1 (0)
 other reason
1 (0)
0 (0)
0 (0)
a Proportion of positive among those from whom information was available
b Dry skin / atopy / acne / insect stings excluded, sunburn / sun rash / infected skin due to insect stings included
c Five travelers reported two or more causes of visit
d Including travelers seeing a doctor because of any skin problem (e.g. insect stings, allergic reactions)
During follow-up, about one-third reported new-onset health problems (Table 7). Their most common single symptom was fever, followed by respiratory tract infection, skin problems, and TD.

Discussion

Introduction

Investigations addressing travelers’ health have generally been retrospective and/or conducted on those seeking medical care after their journeys, whereas prospective studies are scarce. Furthermore, research tends to focus on the effects that one or just a few specific factors have on travelers’ behavior and illness: destination [4, 26, 27], length of journey [4, 5, 26, 27], purpose of travel [27], gender [4, 5, 26, 27], age [4, 5, 26, 27], risk behavior [5], and particular diseases, such as TD [3441]. We are not aware of any earlier investigations into all these factors with a single prospective cohort of travelers; only one [4] provides data on the same subjects during and after travel, and at follow-up.

Morbidity during travel and on return

A central finding of our work is high morbidity rate. Despite efficient prophylactic measures taken before travel – exemplified by our vaccination data – the amount of health problems proved striking: as many as 76 % of our subjects reported illness while abroad, and 25 % still had ongoing symptoms or new complaints within two days after returning home. The overall proportion of our subjects with any symptoms while overseas (76 %) correspond to that reported for American (64 %; [4]), U.K. (64 %; [25]), and Israeli travelers (70 %; [5]), but proved higher than percentages presented for German (10-43 %; [26, 27]), Swiss (38 %; [24]), and Swedish travelers (49 %; [23]). As all these investigations are based on questionnaires, the format of the various questions concerning symptoms may account for the differences.
As regards morbidity in different geographic regions, the percentage of illness proved, as expected, significantly smaller for travelers to advanced countries (20 %) than those visiting developing regions (81 %); the rates were highest for visitors to Southern Asia, South-Eastern Asia, and Eastern Africa. TD accounted for the majority of health problems while abroad / after return (69 %). This result accords with several previous studies [46, 8, 10, 2124, 26, 27, 4244].

Morbidity at follow-up

While the symptoms of illness mostly set in abroad, the figures proved unexpectedly high also during the follow-up: new health problems were reported by 32 % of our subjects. This percentage slightly exceeds the result of the only previous study exploring illness on return and at follow-up; the morbidity rate reported by Hill is 26 % [4]. The duration of follow-up may account for the small difference. In our study it was somewhat shorter (three weeks vs two months). But since the subjects were not asked to give exact dates for their symptoms, the onset could afterwards not be limited to 14 days in cases of TD, respiratory illness, and skin disorders, like in Hill’s report.
At follow-up, the four leading symptoms were fever, skin problems, respiratory illness, and TD, a finding according with Hill’s results [4]. In our study, fever was the most frequent single symptom – often associated with TD. Diarrhea remained the most common cause for seeking health care.

Profiles

The data revealed regional differences which enabled profiling our subjects: travelers to Africa tended to be older and more cautious than those visiting Asia, whereas visitors to Asia were typically younger and favored longer trips. Likewise, the data show differences between travelers by age: the young traveled for longest and stayed in guest houses more frequently than the others, were the most likely to eat uncooked meat/fish and salads, not to use utensils, to follow a vegetarian diet, to neglect hand washing, and not to avoid freshwater contact. Not surprisingly, the longer the stay overseas, the lower the degree of travelers’ compliance with hygiene instructions. Such traveler profiles can be used as a tool to target advice at various groups according to their special characteristics.

Risk factors

Destination, gender, age, and duration of travel were shown by multivariable analysis to be factors predisposing to illness. Southern Asia proved the riskiest resort, as also reported in earlier studies [4, 26]. Female travelers proved to be at greater risk of acquiring symptoms (OR 1.7), a finding according with the results published by Hill [4]. In the present data, each day increased the risk of contracting illness by 2.5 %; the respective figure obtained by Hill was 3.1–3.7 % [4]. Young age has often been reported to be associated with illness [4, 5, 8, 23, 26, 27]; in our cohort the risk was highest at 31.5 years. Eating raw meat or fish proved to be a protective factor. The reasons for this are not obvious and can only be speculated on.

Limitations of the study

The present investigation has some limitations which deserve to be discussed. Firstly, the results are not representative of all travelers, but of volunteers with pre-travel appointments at a travel clinic. Thus visitors to Africa and other developing regions were overrepresented. Secondly, due to small sample size, statistical analyses of some subgroups were poorly powered. The third limitation concerns the follow-up: the reliability of the conclusions suffers from the fact that only 51 % of our volunteers completed the questionnaire, and many delivered it later than requested. Importantly, however, even if it could be assumed that none of the remaining 49 % had been ill, the number of newly onset symptoms during follow-up remains substantial. The data would have benefited from a comparison to non-traveling controls. Our data collection can also be regarded as a limitation, for questionnaire-based studies may distort the results in various ways. Due to the common use of questionnaires, this tends to be characteristic of research into travelers’ health problems [3, 4, 6, 2227, 42, 4448]; a few previous reports include data collected by telephone surveys [2, 4, 5, 8, 27]. In our study, travel diaries may have improved the accuracy of data to some degree. The exact number of clients declining to participate was not recorded. However, based on the number of clients seen by the recruiting doctor and number of those recruited, we estimate that at the maximum 10 % of the potentially eligible clients declined.

Our data in relation to previous estimates of travelers’ health problems

We recently reported incidences of illness and injury among more than 50 000 Finnish travelers visiting various regions [21] by relating cases recorded by an assistance organization to numbers of travelers to each region. The results were considered to cover the most severe cases. The present data complete that picture by showing even the mildest symptoms contracted. This puts the two studies into perspective. Since 90 % of our travelers did not contact health care, the proportion covered by our previous report may not amount to more than 10 % of the illness altogether – slightly less than estimated in that study [21]. The strengths of the present research include the prospective study design and the fact that we combined data of three time points (pre-travel, travel/return, and follow-up) for a single cohort. Interestingly, the rate of health problems per region presented in our study accords with risk estimates presented by International SOS (Additional file 2: Figure S2).
Advice on malaria prophylaxis is a cornerstone of pre-travel appointments. In our data, 289 of the 296 travelers (98 %) taking malaria prophylaxis reported compliance. Interestingly, however, four of them, all diagnosed in Africa, were also treated for malaria while abroad. One case was microbiologically verified, two reported a negative malaria test, and one had taken medication without laboratory diagnostics. Our earlier data collected by the assistance organization shows malaria to be rare in travelers (8/50000 cases; Siikamäki, personal communication). Indeed, the diagnoses of our cases may not be correct, as presumptive treatment is often given in Africa [49], and malaria diagnostics may not always be accurate [50].

Conclusions

This study with most of its subjects visiting (sub)tropical regions shows that, despite efficient preventive measures like vaccinations, malaria prophylaxis, and travel advice, the majority fall ill during or after travel. TD is the most common disease while abroad, followed by skin problems and fever. After travel, the most frequent complaints are fever, respiratory tract infections, and skin problems. Symptoms generally remain mild, not requiring medical care. The proportion of newly onset illness among returning travelers is considerable: one-third get health problems after their journeys. Advice regarding this should be given already at pre-travel appointments.

Abbreviations

TD, Travelers’ diarrhea

Acknowledgements

We express our gratitude to the late Dr Jukka Riutta for recruiting the patients. We thank the nurses at the Travel Clinic of Aava Medical Centre for help in recruiting the volunteers, and the personnel of Helsinki University Hospital Laboratory for assistance with the collection of questionnaires. Jukka Ollgren (National Institute for Health and Welfare, Helsinki, Finland) is acknowledged for advice in statistical analyses.

Funding

The work was supported by the Finnish Governmental Subsidy for Health Science Research and by the Scandinavian Society for Antimicrobial Chemotherapy Foundation. The funding sources had no involvement in study design, data collection, analysis, data interpretation, writing of the report, and the decision to submit the article for publication.

Availability of data and materials

Data not available.

Authors’ contributions

Study concept and design, KV, AK; acquisition of data, KV, SHP, TL, AK; analysis and interpretation of data, KV, SHP, TL, AK; statistical analysis, KV; drafting of the manuscript, KV, AK; critical comments on the manuscript, SHP, TL, HS; final approval of the version published, KV, SHP, TL, HS, AK. All authors have read and approved the final version of the manuscript.

Authors’ information

Not applicable.

Competing interests

The authors declare that they have no competing interests.
Not applicable.
The study protocol was approved by the Ethics Committee of Helsinki University Hospital. Written informed consent was obtained from all subjects.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Anhänge

Additional files

Literatur
2.
Zurück zum Zitat Duval B, De Serre G, Shadmani R, Boulianne N, Pohani G, Naus M, et al. A population-based comparison between travelers who consulted travel clinics and those who did not. J Travel Med. 2003;10(1):4–10.CrossRefPubMed Duval B, De Serre G, Shadmani R, Boulianne N, Pohani G, Naus M, et al. A population-based comparison between travelers who consulted travel clinics and those who did not. J Travel Med. 2003;10(1):4–10.CrossRefPubMed
3.
Zurück zum Zitat Wilder-Smith A, Khairullah NS, Song JH, Chen CY, Torresi J. Travel health knowledge, attitudes and practices among Australasian travelers. J Travel Med. 2004;11(1):9–15.CrossRefPubMed Wilder-Smith A, Khairullah NS, Song JH, Chen CY, Torresi J. Travel health knowledge, attitudes and practices among Australasian travelers. J Travel Med. 2004;11(1):9–15.CrossRefPubMed
4.
Zurück zum Zitat Hill DR. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med. 2000;7(5):259–66.CrossRefPubMed Hill DR. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med. 2000;7(5):259–66.CrossRefPubMed
5.
Zurück zum Zitat Winer L, Alkan M. Incidence and precipitating factors of morbidity among Israeli travelers abroad. J Travel Med. 2002;9(5):227–32.CrossRefPubMed Winer L, Alkan M. Incidence and precipitating factors of morbidity among Israeli travelers abroad. J Travel Med. 2002;9(5):227–32.CrossRefPubMed
6.
Zurück zum Zitat Kemmerer TP, Cetron M, Harper L, Kozarsky PE. Health problems of corporate travelers: risk factors and management. J Travel Med. 1998;5(4):184–7.CrossRefPubMed Kemmerer TP, Cetron M, Harper L, Kozarsky PE. Health problems of corporate travelers: risk factors and management. J Travel Med. 1998;5(4):184–7.CrossRefPubMed
7.
Zurück zum Zitat Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354(2):119–30.CrossRefPubMed Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354(2):119–30.CrossRefPubMed
8.
Zurück zum Zitat Alon D, Shitrit P, Chowers M. Risk behaviors and spectrum of diseases among elderly travelers: a comparison of younger and older adults. J Travel Med. 2010;17(4):250–5.CrossRefPubMed Alon D, Shitrit P, Chowers M. Risk behaviors and spectrum of diseases among elderly travelers: a comparison of younger and older adults. J Travel Med. 2010;17(4):250–5.CrossRefPubMed
9.
Zurück zum Zitat Siikamaki HM, Kivela PS, Sipila PN, Kettunen A, Kainulainen MK, Ollgren JP, et al. Fever in travelers returning from malaria-endemic areas: don't look for malaria only. J Travel Med. 2011;18(4):239–44.CrossRefPubMed Siikamaki HM, Kivela PS, Sipila PN, Kettunen A, Kainulainen MK, Ollgren JP, et al. Fever in travelers returning from malaria-endemic areas: don't look for malaria only. J Travel Med. 2011;18(4):239–44.CrossRefPubMed
10.
Zurück zum Zitat Flores-Figueroa J, Okhuysen PC, von Sonnenburg F, DuPont HL, Libman MD, Keystone JS, et al. Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis. 2011;53(6):523–31.CrossRefPubMed Flores-Figueroa J, Okhuysen PC, von Sonnenburg F, DuPont HL, Libman MD, Keystone JS, et al. Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis. 2011;53(6):523–31.CrossRefPubMed
11.
Zurück zum Zitat Savini H, Gautret P, Gaudart J, Field V, Castelli F, Lopez-Velez R, et al. Travel-associated diseases, Indian Ocean Islands, 1997-2010. Emerg Infect Dis. 2013;19(8):1297–301.CrossRefPubMedPubMedCentral Savini H, Gautret P, Gaudart J, Field V, Castelli F, Lopez-Velez R, et al. Travel-associated diseases, Indian Ocean Islands, 1997-2010. Emerg Infect Dis. 2013;19(8):1297–301.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Harvey K, Esposito DH, Han P, Kozarsky P, Freedman DO, Plier DA, et al. Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011. MMWR Surveill Summ. 2013;62:1–23.PubMed Harvey K, Esposito DH, Han P, Kozarsky P, Freedman DO, Plier DA, et al. Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011. MMWR Surveill Summ. 2013;62:1–23.PubMed
13.
Zurück zum Zitat Leder K, Torresi J, Brownstein JS, Wilson ME, Keystone JS, Barnett E, et al. Travel-associated illness trends and clusters, 2000-2010. Emerg Infect Dis. 2013;19(7):1049–73.CrossRefPubMedPubMedCentral Leder K, Torresi J, Brownstein JS, Wilson ME, Keystone JS, Barnett E, et al. Travel-associated illness trends and clusters, 2000-2010. Emerg Infect Dis. 2013;19(7):1049–73.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Leder K, Torresi J, Libman MD, Cramer JP, Castelli F, Schlagenhauf P, et al. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med. 2013;158(6):456–68.CrossRefPubMedPubMedCentral Leder K, Torresi J, Libman MD, Cramer JP, Castelli F, Schlagenhauf P, et al. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med. 2013;158(6):456–68.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Boggild AK, Geduld J, Libman M, Ward BJ, McCarthy AE, Doyle PW, et al. Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009-2011. Open Med. 2014;8(1):e20–32.PubMedPubMedCentral Boggild AK, Geduld J, Libman M, Ward BJ, McCarthy AE, Doyle PW, et al. Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009-2011. Open Med. 2014;8(1):e20–32.PubMedPubMedCentral
16.
Zurück zum Zitat Hagmann SH, Han PV, Stauffer WM, Miller AO, Connor BA, Hale DC, et al. Travel-associated disease among US residents visiting US GeoSentinel clinics after return from international travel. Fam Pract. 2014;31(6):678–87.CrossRefPubMedPubMedCentral Hagmann SH, Han PV, Stauffer WM, Miller AO, Connor BA, Hale DC, et al. Travel-associated disease among US residents visiting US GeoSentinel clinics after return from international travel. Fam Pract. 2014;31(6):678–87.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Wilson ME, Chen LH, Han PV, Keystone JS, Cramer JP, Segurado A, et al. Illness in travelers returned from Brazil: the GeoSentinel experience and implications for the 2014 FIFA World Cup and the 2016 Summer Olympics. Clin Infect Dis. 2014;58(10):1347–56.CrossRefPubMed Wilson ME, Chen LH, Han PV, Keystone JS, Cramer JP, Segurado A, et al. Illness in travelers returned from Brazil: the GeoSentinel experience and implications for the 2014 FIFA World Cup and the 2016 Summer Olympics. Clin Infect Dis. 2014;58(10):1347–56.CrossRefPubMed
18.
Zurück zum Zitat Mendelson M, Han PV, Vincent P, von Sonnenburg F, Cramer JP, Loutan L, et al. Regional variation in travel-related illness acquired in Africa, March 1997-May 2011. Emerg Infect Dis. 2014;20(4):532–41.CrossRefPubMedPubMedCentral Mendelson M, Han PV, Vincent P, von Sonnenburg F, Cramer JP, Loutan L, et al. Regional variation in travel-related illness acquired in Africa, March 1997-May 2011. Emerg Infect Dis. 2014;20(4):532–41.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Al-Abri SS, Abdel-Hady DM, Al Mahrooqi SS, Al-Kindi HS, Al-Jardani AK, Al-Abaidani IS. Epidemiology of travel-associated infections in Oman 1999-2013: A retrospective analysis. Travel Med Infect Dis. 2015;13(5):388–93.CrossRefPubMed Al-Abri SS, Abdel-Hady DM, Al Mahrooqi SS, Al-Kindi HS, Al-Jardani AK, Al-Abaidani IS. Epidemiology of travel-associated infections in Oman 1999-2013: A retrospective analysis. Travel Med Infect Dis. 2015;13(5):388–93.CrossRefPubMed
20.
Zurück zum Zitat Boggild AK, Esposito DH, Kozarsky PE, Ansdell V, Beeching NJ, Campion D, et al. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med. 2015;162(11):757–64.CrossRefPubMedPubMedCentral Boggild AK, Esposito DH, Kozarsky PE, Ansdell V, Beeching NJ, Campion D, et al. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med. 2015;162(11):757–64.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Siikamaki H, Kivela P, Fotopoulos M, Ollgren J, Kantele A. Illness and injury of travellers abroad: Finnish nationwide data from 2010 to 2012, with incidences in various regions of the world. Euro Surveill. 2015;20(19):15–26.CrossRefPubMed Siikamaki H, Kivela P, Fotopoulos M, Ollgren J, Kantele A. Illness and injury of travellers abroad: Finnish nationwide data from 2010 to 2012, with incidences in various regions of the world. Euro Surveill. 2015;20(19):15–26.CrossRefPubMed
22.
Zurück zum Zitat Getz L, Larssen KE, Dahl B, Westin S. Health problems in Norwegians travelling to distant countries. Scand J Prim Health Care. 1990;8(2):95–100.CrossRefPubMed Getz L, Larssen KE, Dahl B, Westin S. Health problems in Norwegians travelling to distant countries. Scand J Prim Health Care. 1990;8(2):95–100.CrossRefPubMed
23.
Zurück zum Zitat Ahlm C, Lundberg S, Fesse K, Wistrom J. Health problems and self-medication among Swedish travellers. Scand J Infect Dis. 1994;26(6):711–7.CrossRefPubMed Ahlm C, Lundberg S, Fesse K, Wistrom J. Health problems and self-medication among Swedish travellers. Scand J Infect Dis. 1994;26(6):711–7.CrossRefPubMed
24.
Zurück zum Zitat Bruni M, Steffen R. Impact of Travel-Related Health Impairments. J Travel Med. 1997;4(2):61–4.CrossRefPubMed Bruni M, Steffen R. Impact of Travel-Related Health Impairments. J Travel Med. 1997;4(2):61–4.CrossRefPubMed
25.
Zurück zum Zitat Evans MR, Shickle D, Morgan MZ. Travel illness in British package holiday tourists: prospective cohort study. J Infect. 2001;43(2):140–7.CrossRefPubMed Evans MR, Shickle D, Morgan MZ. Travel illness in British package holiday tourists: prospective cohort study. J Infect. 2001;43(2):140–7.CrossRefPubMed
26.
Zurück zum Zitat Rack J, Wichmann O, Kamara B, Gunther M, Cramer J, Schonfeld C, et al. Risk and spectrum of diseases in travelers to popular tourist destinations. J Travel Med. 2005;12(5):248–53.CrossRefPubMed Rack J, Wichmann O, Kamara B, Gunther M, Cramer J, Schonfeld C, et al. Risk and spectrum of diseases in travelers to popular tourist destinations. J Travel Med. 2005;12(5):248–53.CrossRefPubMed
27.
Zurück zum Zitat Fleck S, Jager H, Zeeb H. Travel and health status: a survey follow-up study. Eur J Public Health. 2006;16(1):96–100.CrossRefPubMed Fleck S, Jager H, Zeeb H. Travel and health status: a survey follow-up study. Eur J Public Health. 2006;16(1):96–100.CrossRefPubMed
28.
Zurück zum Zitat Kantele A, Laaveri T, Mero S, Vilkman K, Pakkanen SH, Ollgren J, et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60(6):837–46.CrossRefPubMedPubMedCentral Kantele A, Laaveri T, Mero S, Vilkman K, Pakkanen SH, Ollgren J, et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60(6):837–46.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Antikainen J, Kantele A, Pakkanen SH, Laaveri T, Riutta J, Vaara M, et al. A quantitative polymerase chain reaction assay for rapid detection of 9 pathogens directly from stools of travelers with diarrhea. Clin Gastroenterol Hepatol. 2013;11(10):1300–7. e3.CrossRefPubMed Antikainen J, Kantele A, Pakkanen SH, Laaveri T, Riutta J, Vaara M, et al. A quantitative polymerase chain reaction assay for rapid detection of 9 pathogens directly from stools of travelers with diarrhea. Clin Gastroenterol Hepatol. 2013;11(10):1300–7. e3.CrossRefPubMed
30.
Zurück zum Zitat Laaveri T, Antikainen J, Pakkanen SH, Kirveskari J, Kantele A: Prospective study of pathogens in asymptomatic travellers and those with diarrhoea: aetiological agents revisited. Clin Microbiol Infect 2016, in press. Laaveri T, Antikainen J, Pakkanen SH, Kirveskari J, Kantele A: Prospective study of pathogens in asymptomatic travellers and those with diarrhoea: aetiological agents revisited. Clin Microbiol Infect 2016, in press.
34.
Zurück zum Zitat Mattila L, Siitonen A, Kyronseppa H, Simula II, Peltola H. Risk Behavior for Travelers' Diarrhea Among Finnish Travelers. J Travel Med. 1995;2(2):77–84.CrossRefPubMed Mattila L, Siitonen A, Kyronseppa H, Simula II, Peltola H. Risk Behavior for Travelers' Diarrhea Among Finnish Travelers. J Travel Med. 1995;2(2):77–84.CrossRefPubMed
35.
Zurück zum Zitat Steffen R, Tornieporth N, Clemens SA, Chatterjee S, Cavalcanti AM, Collard F, et al. Epidemiology of travelers' diarrhea: details of a global survey. J Travel Med. 2004;11(4):231–7.CrossRefPubMed Steffen R, Tornieporth N, Clemens SA, Chatterjee S, Cavalcanti AM, Collard F, et al. Epidemiology of travelers' diarrhea: details of a global survey. J Travel Med. 2004;11(4):231–7.CrossRefPubMed
36.
Zurück zum Zitat Cabada MM, Maldonado F, Quispe W, Mozo K, Serrano E, Gonzalez E, et al. Risk factors associated with diarrhea among international visitors to Cuzco, Peru. Am J Trop Med Hyg. 2006;75(5):968–72.PubMed Cabada MM, Maldonado F, Quispe W, Mozo K, Serrano E, Gonzalez E, et al. Risk factors associated with diarrhea among international visitors to Cuzco, Peru. Am J Trop Med Hyg. 2006;75(5):968–72.PubMed
37.
Zurück zum Zitat Laverone E, Boccalini S, Bechini A, Belli S, Santini MG, Baretti S, et al. Travelers' compliance to prophylactic measures and behavior during stay abroad: results of a retrospective study of subjects returning to a travel medicine center in Italy. J Travel Med. 2006;13(6):338–44.CrossRefPubMed Laverone E, Boccalini S, Bechini A, Belli S, Santini MG, Baretti S, et al. Travelers' compliance to prophylactic measures and behavior during stay abroad: results of a retrospective study of subjects returning to a travel medicine center in Italy. J Travel Med. 2006;13(6):338–44.CrossRefPubMed
38.
Zurück zum Zitat Piyaphanee W, Kusolsuk T, Kittitrakul C, Suttithum W, Ponam T, Wilairatana P. Incidence and impact of travelers' diarrhea among foreign backpackers in Southeast Asia: a result from Khao San road, Bangkok. J Travel Med. 2011;18(2):109–14.CrossRefPubMed Piyaphanee W, Kusolsuk T, Kittitrakul C, Suttithum W, Ponam T, Wilairatana P. Incidence and impact of travelers' diarrhea among foreign backpackers in Southeast Asia: a result from Khao San road, Bangkok. J Travel Med. 2011;18(2):109–14.CrossRefPubMed
39.
Zurück zum Zitat Kasper MR, Lescano AG, Lucas C, Gilles D, Biese BJ, Stolovitz G, et al. Diarrhea outbreak during U.S. military training in El Salvador. PLoS One. 2012;7(7):e40404.CrossRefPubMedPubMedCentral Kasper MR, Lescano AG, Lucas C, Gilles D, Biese BJ, Stolovitz G, et al. Diarrhea outbreak during U.S. military training in El Salvador. PLoS One. 2012;7(7):e40404.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Launders NJ, Nichols GL, Cartwright R, Lawrence J, Jones J, Hadjichristodoulou C. Self-reported stomach upset in travellers on cruise-based and land-based package holidays. PLoS One. 2014;9(1):e83425.CrossRefPubMedPubMedCentral Launders NJ, Nichols GL, Cartwright R, Lawrence J, Jones J, Hadjichristodoulou C. Self-reported stomach upset in travellers on cruise-based and land-based package holidays. PLoS One. 2014;9(1):e83425.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Kittitrakul C, Lawpoolsri S, Kusolsuk T, Olanwijitwong J, Tangkanakul W, Piyaphanee W. Traveler's Diarrhea in Foreign Travelers in Southeast Asia: A Cross-Sectional Survey Study in Bangkok, Thailand. Am J Trop Med Hyg. 2015;93(3):485–90.CrossRefPubMedPubMedCentral Kittitrakul C, Lawpoolsri S, Kusolsuk T, Olanwijitwong J, Tangkanakul W, Piyaphanee W. Traveler's Diarrhea in Foreign Travelers in Southeast Asia: A Cross-Sectional Survey Study in Bangkok, Thailand. Am J Trop Med Hyg. 2015;93(3):485–90.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Reid D, Dewar RD, Fallon RJ, Cossar JH, Grist NR. Infection and travel: the experience of package tourists and other travellers. J Infect. 1980;2(4):365–70.CrossRefPubMed Reid D, Dewar RD, Fallon RJ, Cossar JH, Grist NR. Infection and travel: the experience of package tourists and other travellers. J Infect. 1980;2(4):365–70.CrossRefPubMed
43.
Zurück zum Zitat Schlagenhauf P, Chen LH, Wilson ME, Freedman DO, Tcheng D, Schwartz E, et al. Sex and gender differences in travel-associated disease. Clin Infect Dis. 2010;50(6):826–32.CrossRefPubMed Schlagenhauf P, Chen LH, Wilson ME, Freedman DO, Tcheng D, Schwartz E, et al. Sex and gender differences in travel-associated disease. Clin Infect Dis. 2010;50(6):826–32.CrossRefPubMed
44.
Zurück zum Zitat Mackaness CA, Osborne A, Verma D, Templer S, Weiss MJ, Knouse MC. A quality improvement initiative using a novel travel survey to promote patient-centered counseling. J Travel Med. 2013;20(4):237–42.CrossRefPubMed Mackaness CA, Osborne A, Verma D, Templer S, Weiss MJ, Knouse MC. A quality improvement initiative using a novel travel survey to promote patient-centered counseling. J Travel Med. 2013;20(4):237–42.CrossRefPubMed
45.
Zurück zum Zitat Reed JM, McIntosh IB, Powers K. Travel Illness and the Family Practitioner: A Retrospective Assessment of Travel-Induced Illness in General Practice and the Effect of a Travel Illness Clinic. J Travel Med. 1994;1(4):192–8.CrossRefPubMed Reed JM, McIntosh IB, Powers K. Travel Illness and the Family Practitioner: A Retrospective Assessment of Travel-Induced Illness in General Practice and the Effect of a Travel Illness Clinic. J Travel Med. 1994;1(4):192–8.CrossRefPubMed
46.
Zurück zum Zitat Lee VJ, Wilder-Smith A. Travel characteristics and health practices among travellers at the travellers' health and vaccination clinic in Singapore. Ann Acad Med Singapore. 2006;35(10):667–73.PubMed Lee VJ, Wilder-Smith A. Travel characteristics and health practices among travellers at the travellers' health and vaccination clinic in Singapore. Ann Acad Med Singapore. 2006;35(10):667–73.PubMed
47.
Zurück zum Zitat Goesch JN, Simons de Fanti A, Bechet S, Consigny PH. Comparison of knowledge on travel related health risks and their prevention among humanitarian aid workers and other travellers consulting at the Institut Pasteur travel clinic in Paris, France. Travel Med Infect Dis. 2010;8(6):364–72.CrossRefPubMed Goesch JN, Simons de Fanti A, Bechet S, Consigny PH. Comparison of knowledge on travel related health risks and their prevention among humanitarian aid workers and other travellers consulting at the Institut Pasteur travel clinic in Paris, France. Travel Med Infect Dis. 2010;8(6):364–72.CrossRefPubMed
48.
Zurück zum Zitat Buhler S, Ruegg R, Steffen R, Hatz C, Jaeger VK. A profile of travelers--an analysis from a large swiss travel clinic. J Travel Med. 2014;21(5):324–31.CrossRefPubMed Buhler S, Ruegg R, Steffen R, Hatz C, Jaeger VK. A profile of travelers--an analysis from a large swiss travel clinic. J Travel Med. 2014;21(5):324–31.CrossRefPubMed
49.
Zurück zum Zitat Vialle-Valentin CE, LeCates RF, Zhang F, Ross-Degnan D. Treatment of Febrile illness with artemisinin combination therapy: prevalence and predictors in five African household surveys. J Pharm Policy Pract. 2015;8(1):1. 014-0024-0. eCollection 2015.CrossRefPubMedPubMedCentral Vialle-Valentin CE, LeCates RF, Zhang F, Ross-Degnan D. Treatment of Febrile illness with artemisinin combination therapy: prevalence and predictors in five African household surveys. J Pharm Policy Pract. 2015;8(1):1. 014-0024-0. eCollection 2015.CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Kahama-Maro J, D'Acremont V, Mtasiwa D, Genton B, Lengeler C. Low quality of routine microscopy for malaria at different levels of the health system in Dar es Salaam. Malar J. 2011;10:332. 2875-10-332.CrossRefPubMedPubMedCentral Kahama-Maro J, D'Acremont V, Mtasiwa D, Genton B, Lengeler C. Low quality of routine microscopy for malaria at different levels of the health system in Dar es Salaam. Malar J. 2011;10:332. 2875-10-332.CrossRefPubMedPubMedCentral
Metadaten
Titel
Travelers’ health problems and behavior: prospective study with post-travel follow-up
verfasst von
Katri Vilkman
Sari H. Pakkanen
Tinja Lääveri
Heli Siikamäki
Anu Kantele
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2016
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1682-0

Weitere Artikel der Ausgabe 1/2016

BMC Infectious Diseases 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.